Thio Pharma Holding B.V.
Thio Pharma Holding B.V., commonly referred to as Thio Pharma, is a prominent player in the pharmaceutical industry, headquartered in the Netherlands. Established in 2005, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of oncology and infectious diseases. With a strong operational presence across Europe and beyond, Thio Pharma is dedicated to delivering innovative solutions that address unmet medical needs. Their core offerings include a range of advanced therapeutic agents, distinguished by their unique formulations and commitment to efficacy and safety. Recognised for its robust research and development capabilities, Thio Pharma has achieved notable milestones, positioning itself as a trusted partner in the global healthcare landscape. The company continues to focus on expanding its market reach while maintaining its commitment to excellence in pharmaceutical manufacturing.
DitchCarbon Score
How does Thio Pharma Holding B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Thio Pharma Holding B.V.'s score of 18 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Thio Pharma Holding B.V.'s reported carbon emissions
Thio Pharma Holding B.V., headquartered in the Netherlands (NL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Thio Pharma Holding B.V. appears to lack formal commitments to carbon reduction initiatives or industry-standard climate strategies, such as those outlined by the Science Based Targets initiative (SBTi) or other recognised frameworks. Without emissions data or reduction targets, it is challenging to assess the company's environmental impact or commitment to sustainability. In the context of the pharmaceutical industry, companies are increasingly expected to adopt transparent climate strategies and set measurable targets to mitigate their carbon footprints. However, Thio Pharma Holding B.V. has not yet established such frameworks or reported relevant emissions data.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Thio Pharma Holding B.V. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
